Bernardo, Judith R.
HRN: 22-55-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
CLINDAMYCIN 150MG (CAP)
02/02/2023
02/08/2023
IV
600mg
Q8h
Perianal Abscess
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes